Melissa B. Epperly, Chief Financial Officer at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 5,783 shares at $37.45 ($217K) on 2021-02-01, disclosed to the SEC on 2021-02-03.
Open-market sale of $217k ZNTL by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.45 | 2,700 | $101K | 46.6% |
| 2 | $37.45 | 2,700 | $101K | 46.6% |
| 3 | $38.33 | 383 | $15K | 6.8% |
| Total | $37.51 avg | 5,783 | $217K | 100% |
| Filing → |
| ROIV | SELL | 2026-07-01 | $610K | — | Filing → |
| ROIV | SELL | 2026-03-18 | $1.2M | — | Filing → |
| ZNTL | SELL | 2024-02-12 | $29K | — | Filing → |